Consolidating the value of the standardised ARC-HBR definition
- 1 February 2021
- journal article
- editorial
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 16 (14), 1126-1128
- https://doi.org/10.4244/eijv16i14a202
Abstract
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Keywords
This publication has 12 references indexed in Scilit:
- Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trialsEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2020
- Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding riskEuropean Heart Journal, 2020
- Prevalence of the Academic Research Consortium for High Bleeding Risk Criteria and Prognostic Value of a Simplified DefinitionCirculation Journal, 2020
- Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scoresEuroIntervention, 2020
- Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI PatientsJournal of the American College of Cardiology, 2020
- Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding RiskCirculation, 2020
- Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2019
- Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding RiskEuropean Heart Journal, 2019
- Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trialEuropean Heart Journal, 2016
- Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent ImplantationJournal of the American College of Cardiology, 2015